What's new

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised

Feb 20, 2025 - 14:30
 0
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

Orphan designation: Camostat mesilate Treatment of chronic pancreatitis, 16/01/2...

Next Article

New Look liquidates Irish business

Related Posts

3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 April 2025, 09:30 (CEST) to 2 April 2025, 10:30 (CEST)

3Rs Working Party (3RsWP) plenary meeting - Public sess...

Mar 5, 2025  0

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

EMEA-001318-PIP01-12-M05

EMEA-001318-PIP01-12-M05

Feb 14, 2025  0